Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Olshansky

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Archives of Internal Medicine|June 29, 2000
Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and ElectrophysiologyN Goldschlager, A E Epstein, G Naccarelli, et al.
Circulation|December 1, 1984
Variation of left ventricular myocardial gray level on two-dimensional echocardiograms as a result of cardiac contractionB Olshansky, S M Collins, D J Skorton, et al.
The American Journal of Cardiology|November 15, 2000
Case 4: a patient with symptomatic bradycardiaD J Newton, B Olshansky, J P Ornato, et al.
Circulation|January 1, 1993
Adenosine-sensitive ventricular tachycardia. Clinical characteristics and response to catheter ablationD J Wilber, J Baerman, B Olshansky, et al.
The American Journal of Cardiology|October 12, 2000
Location of death (in-hospital or out-of-hospital) and type of death (arrhythmic, nonarrhythmic, noncardiac) after inducible sustained ventricular tachyarrhythmias after syncope, sustained ventricular tachycardia, or nonfatal cardiac arrest (the ESVEM trial)B Olshansky, V Hartz, E Hahn, et al.
Circulation|August 1, 1990
Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular functionD J Wilber, B Olshansky, J F Moran, et al.
Archives of Internal Medicine|March 20, 2001
Environmental and drug effects on patients with pacemakers and implantable cardioverter/defibrillators: a practical guide to patient treatmentN Goldschlager, A Epstein, P Friedman, et al.
Progress in Cardiovascular Diseases|November 1, 1993
Nonsustained ventricular tachycardia and other high-risk predictors following myocardial infarction: implications for prophylactic automatic implantable cardioverter-defibrillator useD J Wilber, D Kopp, B Olshansky, et al.
Anesthesiology|January 1, 1997
Apparent failure of a precordial magnet and pacemaker programmer to convert a DDD pacemaker to VOO mode during the use of the electrosurgical unitB Kleinman, J Hamilton, R Hariman, et al.
Pacing and Clinical Electrophysiology : PACE|April 1, 1994
The clinical significance of nonsustained ventricular tachycardia: current perspectivesC Kinder, P Tamburro, D Kopp, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Archives of Internal Medicine|June 29, 2000
Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and ElectrophysiologyN Goldschlager, A E Epstein, G Naccarelli, et al.
Circulation|December 1, 1984
Variation of left ventricular myocardial gray level on two-dimensional echocardiograms as a result of cardiac contractionB Olshansky, S M Collins, D J Skorton, et al.
The American Journal of Cardiology|November 15, 2000
Case 4: a patient with symptomatic bradycardiaD J Newton, B Olshansky, J P Ornato, et al.
Circulation|January 1, 1993
Adenosine-sensitive ventricular tachycardia. Clinical characteristics and response to catheter ablationD J Wilber, J Baerman, B Olshansky, et al.
The American Journal of Cardiology|October 12, 2000
Location of death (in-hospital or out-of-hospital) and type of death (arrhythmic, nonarrhythmic, noncardiac) after inducible sustained ventricular tachyarrhythmias after syncope, sustained ventricular tachycardia, or nonfatal cardiac arrest (the ESVEM trial)B Olshansky, V Hartz, E Hahn, et al.
Circulation|August 1, 1990
Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular functionD J Wilber, B Olshansky, J F Moran, et al.
Archives of Internal Medicine|March 20, 2001
Environmental and drug effects on patients with pacemakers and implantable cardioverter/defibrillators: a practical guide to patient treatmentN Goldschlager, A Epstein, P Friedman, et al.
Progress in Cardiovascular Diseases|November 1, 1993
Nonsustained ventricular tachycardia and other high-risk predictors following myocardial infarction: implications for prophylactic automatic implantable cardioverter-defibrillator useD J Wilber, D Kopp, B Olshansky, et al.
Anesthesiology|January 1, 1997
Apparent failure of a precordial magnet and pacemaker programmer to convert a DDD pacemaker to VOO mode during the use of the electrosurgical unitB Kleinman, J Hamilton, R Hariman, et al.
Pacing and Clinical Electrophysiology : PACE|April 1, 1994
The clinical significance of nonsustained ventricular tachycardia: current perspectivesC Kinder, P Tamburro, D Kopp, et al.
Pageof 9